Tripterygium glycosides tablet ameliorates renal tubulointerstitial fibrosis via the toll-like receptor 4/nuclear factor kappa B signaling pathway in high-fat diet fed and streptozotocin-induced diabetic rats

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Ma, Ze Jun ^a   Zhang, Xiao Na ^a   Li, Li ^a   Yang, Wei ^a   Wang, Shan Shan ^a   Guo, Xin ^a   Sun, Pei ^a   Chen, Li Ming ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIINFLAMMATORY AGENT; CHINESE DRUG; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT GLYCOSIDE; PROTECTIVE AGENT; TOLL LIKE RECEPTOR 4; TRIPTERYGIUM GLYCOSIDE; UNCLASSIFIED DRUG; UVOMORULIN; ACTIN; CADHERIN; GLUCOSE BLOOD LEVEL; GLYCOSIDE; HERBACEOUS AGENT; STREPTOZOCIN; TLR4 PROTEIN, RAT;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; LIPID DIET; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; RENAL TUBULOINTERSTITIAL FIBROSIS; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TABLET; TREATMENT DURATION; TRIPTERYGIUM WILFORDII; ANALYSIS; ANIMAL; BLOOD; CHEMISTRY; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; INFLAMMATION; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE; SPRAGUE DAWLEY RAT; TRICHOME; TRIPTERYGIUM; URINE;

ACETYLGLUCOSAMINIDASE; ACTINS; ANIMALS; BLOOD GLUCOSE; CADHERINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GLYCOSIDES; INFLAMMATION; KIDNEY; KIDNEY TUBULES; MALE; MUSCLE, SMOOTH; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN; TOLL-LIKE RECEPTOR 4; TRICHOMES; TRIPTERYGIUM;

EID: 84940392509     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/390428     Document Type: Article

References (42)

1. A. T. Reutens and R. C. Atkins, "Epidemiology of diabetic nephropathy, " Contributions to Nephrology, vol. 170, pp. 1-7, 2011.
2. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, "Global estimates of the prevalence of diabetes for 2010 and 2030, " Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4-14, 2010.
3. C. W. Park, "Diabetic kidney disease: from epidemiology to clinical perspectives, " Diabetes & Metabolism Journal, vol. 38, no. 4, pp. 252-260, 2014.
4. S. C. W. Tang, J. C. K. Leung, and K. N. Lai, "Diabetic tubulopathy: an emerging entity, " Contributions to Nephrology, vol. 170, pp. 124-134, 2011.
5. L. Giovanna, V. Francesca, and P. Roberto, "RAAS inhibition and renal protection, " Current Pharmaceutical Design, vol. 18, no. 7, pp. 971-980, 2012.
6. F. Ismail-Beigi, T. Craven, M. A. Banerji, et al., "Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial, " The Lancet, vol. 376, no. 9739, pp. 419-430, 2010.
7. E. M. Abdel-Rahman, L. Saadulla, W. B. Reeves, and A. S. Awad, "Therapeutic modalities in diabetic nephropathy: standard and emerging approaches, " Journal ofGeneral InternalMedicine, vol. 27, no. 4, pp. 458-468, 2012.
8. J. F. Navarro-González and C. Mora-Fernández, "The role of inflammatory cytokines in diabetic nephropathy, " Journal of the American Society ofNephrology, vol. 19, no. 3, pp. 433-442, 2008.
9. M. B. Duran-Salgado and A. F. Rubio-Guerra, "Diabetic nephropathy and inflammation, " World Journal of Diabetes, vol. 5, no. 3, pp. 393-398, 2014.
10. A. K. H. Lim and G. H. Tesch, "Inflammation in diabetic nephropathy, " Mediators of Inflammation, vol. 2012, Article ID 146154, 12 pages, 2012.
11. S. Akira, K. Takeda, and T. Kaisho, "Toll-like receptors: critical proteins linking innate and acquired immunity, " Nature Immunology, vol. 2, no. 8, pp. 675-680, 2001.
12. K. Takeda, T. Kaisho, and S. Akira, "Toll-like receptors, " Annual Review of Immunology, vol. 21, pp. 335-376, 2003.
13. J. F. Navarro-González, C. Mora-Fernández, M. Muros de Fuentes, and J. García-Pérez, "Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy, " Nature Reviews Nephrology, vol. 7, no. 6, pp. 327-340, 2011.
14. S. Mezzano, C. Aros, A. Droguett, et al., "NF-κB activation and overexpression of regulated genes in human diabetic nephropathy, " Nephrology Dialysis Transplantation, vol. 19, no. 10, pp. 2505-2512, 2004.
15. H. Mudaliar, C. Pollock, M. G. Komala, S. Chadban, H. Wu, and U. Panchapakesan, "The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules, " TheAmerican Journal of Physiology-Renal Physiology, vol. 305, no. 2, pp. F143-F154, 2013.
16. M. Lin, W. H. Yiu, H. J. Wu, et al., "Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy, " Journal of the American Society of Nephrology, vol. 23, no. 1, pp. 86-102, 2012.
17. J. Ma, S. J. Chadban, C. Y. Zhao, et al., "TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy, " PLoS ONE, vol. 9, no. 5, Article ID e97985, 2014.
18. P. Liu, F. Li, M. Qiu, and L. He, "Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo, " Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 206-216, 2014.
19. D. Impellizzeri, E. Esposito, J. Attley, and S. Cuzzocrea, "Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD), " Pharmacological Research, vol. 81, pp. 91-102, 2014.
20. B. Zhu, Y. Wang, M. Jardine, et al., "Tripterygium preparations for the treatment of CKD: a systematic review and metaanalysis, " The American Journal of Kidney Diseases, vol. 62, no. 3, pp. 515-530, 2013.
21. Y. Ge, H. Xie, S. Li, et al., "Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial, " Journal of Translational Medicine, vol. 11, no. 1, article 134, 2013.
22. Y. Kong, C. Y. Chan, B. C. Chang, J. H. Yang, M. Y. Zheng, and L. M. Chen, "Effect of Tripterygiumwilfordii Polyglucosides on the expression of tumor necrosis factor-α and interleukin-4 in renal tissue from rats with diabetic nephropathy, " Chinese Journal of Diabetes Mellitus, vol. 9, no. 5, 2013.
23. R. S. Danda, N. M. Habiba, H. Rincon-Choles, et al., "Kidney involvement in a nongenetic rat model of type 2 diabetes, " Kidney International, vol. 68, no. 6, pp. 2562-2571, 2005.
24. R. C. Blantz and P. Singh, "Glomerular and tubular function in the diabetic kidney, " Advances in Chronic Kidney Disease, vol. 21, no. 3, pp. 297-303, 2014.
25. R. E. Gilbert and M. E. Cooper, "The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?" Kidney International, vol. 56, no. 5, pp. 1627-1637, 1999.
26. W. C. Burns and M. C. Thomas, "The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology, " Expert Reviews in Molecular Medicine, vol. 12, article e17, 2010.
27. S. C. W. Tang and K. N. Lai, "The pathogenic role of the renal proximal tubular cell in diabetic nephropathy, " Nephrology Dialysis Transplantation, vol. 27, no. 8, pp. 3049-3056, 2012.
28. R. M. Carew, B. Wang, and P. Kantharidis, "The role of EMT in renal fibrosis, " Cell and Tissue Research, vol. 347, no. 1, pp. 103-116, 2012.
29. Y. Liu, "New insights into epithelial-mesenchymal transition in kidney fibrosis, " Journal of the American Society of Nephrology, vol. 21, no. 2, pp. 212-222, 2010.
30. P. Nisticò, M. J. Bissell, and D. C. Radisky, "Epithelialmesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases, " Cold Spring Harbor Perspectives in Biology, vol. 4, no. 2, 2012.
31. M. Nangaku, "Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure, " Internal Medicine, vol. 43, no. 1, pp. 9-17, 2004.
32. F. Barutta, G. Bruno, S. Grimaldi, and G. Gruden, "Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment, " Endocrine, vol. 48, no. 3, pp. 730-742, 2015.
33. F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, B. J. Rollin, and G. H. Tesch, "Monocyte chemoattractant protein-promotes the development of diabetic renal injury in streptozotocin-treated mice, " Kidney International, vol. 69, no. 1, pp. 73-80, 2006.
34. T. Kawai and S. Akira, "TLR signaling, " Seminars in Immunology, vol. 19, no. 1, pp. 24-32, 2007.
35. T. Kuwabara, K. Mori, M. Mukoyama, et al., "Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Tolllike receptor 4 in mice, " Diabetologia, vol. 55, no. 8, pp. 2256-2266, 2012.
36. T. G. A. M. Wolfs, W. A. Buurman, A. van Schadewijk, et al., " In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation," The Journal of Immunology, vol. 168, no. 3, pp. 1286-1293, 2002.
37. N. Tsuboi, Y. Yoshikai, S. Matsuo, et al., "Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells, "The Journal of Immunology, vol. 169, no. 4, pp. 2026-2033, 2002.
38. P. Chowdhury, S. H. Sacks, and N. S. Sheerin, "Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products, " Clinical and Experimental Immunology, vol. 145, no. 2, pp. 346-356, 2006.
39. C. Chassin, J.-M. Goujon, S. Darche, et al., "Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways, " Journal of Immunology, vol. 177, no. 7, pp. 4773-4784, 2006.
40. T. M. El-Achkar, X. Huang, Z. Plotkin, R. M. Sandoval, G. J. Rhodes, and P. C. Dagher, "Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney, " The American Journal of Physiology-Renal Physiology, vol. 290, no. 5, pp. F1034-F1043, 2006.
41. Y. Pan, Y. Wang, L. Cai, et al., "Inhibition of high glucoseinduced inflammatory response andmacrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats, " British Journal of Pharmacology, vol. 166, no. 3, pp. 1169-1182, 2012.
42. R. Ma, L. Liu, X. Liu, Y. Wang, W. Jiang, and L. Xu, "Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy, " Experimental andTherapeutic Medicine, vol. 6, no. 3, pp. 649-656, 2013.